Yanjun Wang, MD
Internal Medicine · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 557754 · 757662 · El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wang’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A169496 · Current
Licensed to practise in California · since 2020 · expires 2028-07-31 · Huazhong University of Science and Technology, Tongji Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$80,431
Medicare paid this office $80,431 for 428 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 321 | $44,571 | $104 |
| Long return visit (40+ min) | 47 | $8,346 | $152 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $7,704 | $157 |
| Short return visit (20+ min) | 81 | $6,012 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,613 | $154 |
See all 7 services
| Return visit (30+ min) | 321 | $44,571 | $104 |
| Long return visit (40+ min) | 47 | $8,346 | $152 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $7,704 | $157 |
| Short return visit (20+ min) | 81 | $6,012 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,613 | $154 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 58 | $941 | $14 |
| Removal of impacted ear wax by washing | 15 | $226 | $15 |
Who their Medicare patients are
428 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 22% · Women 60% · Also on Medicaid 14% · Health risk score 1.04. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 67% · Diabetes 25% · Chronic kidney disease 21% · Coronary heart disease 20% · Cancer 17% · Depression 15% · Atrial fibrillation 14% · Dementia 12% · Heart failure 10% · COPD 9% · Stroke 9%.
The office billed $266,561, Medicare allowed $111,744 and paid $80,431; for 798 services of 33 kinds; $2,675 of it was for drugs given in the office and $77,755 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 428 | 798 | 77 | 1.04 | $266,561 | $80,431 |
| 2023 | 625 | 1,028 | 76 | 0.92 | $330,627 | $108,713 |
| 2022 | 210 | 450 | 77 | 1.16 | $127,155 | $47,949 |
| 2021 | 147 | 403 | 79 | 1.07 | $118,994 | $46,104 |
| 2020 | 38 | 54 | 76 | 0.93 | $13,695 | $4,313 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 447 | $62,282 | $108 |
| Short return visit (20+ min) | 164 | $13,079 | $73 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 65 | $10,370 | $160 |
| Long return visit (40+ min) | 28 | $6,103 | $170 |
| Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | 14 | $3,378 | $241 |
| New patient visit (45+ min) | 18 | $2,317 | $129 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 13 | $974 | $75 |
| Administration of pneumococcal vaccine | 17 | $597 | $35 |
| Administration of influenza virus vaccine | 14 | $529 | $38 |
| Removal of impacted ear wax by washing | 20 | $356 | $18 |
2022: 6 services
| Return visit (30+ min) | 131 | $21,407 | $111 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 51 | $7,944 | $156 |
| Short return visit (20+ min) | 83 | $7,528 | $76 |
| Long return visit (40+ min) | 12 | $2,211 | $158 |
| Administration of pneumococcal vaccine | 13 | $437 | $34 |
| Removal of impacted ear wax by washing | 11 | $192 | $15 |
2021: 5 services
| Return visit (30+ min) | 79 | $13,861 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 71 | $10,224 | $144 |
| Long return visit (40+ min) | 46 | $9,698 | $154 |
| Short return visit (20+ min) | 41 | $3,028 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,393 | $116 |
2020: 2 services
| Short return visit (20+ min) | 23 | $1,522 | $63 |
| Return visit (30+ min) | 12 | $1,401 | $100 |
Medicaid work
$812 in 2024
Medicaid paid $812 for 20 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 20 | $812 |
| 2024 | 20 | 1 | 18 | $812 |
| 2023 | 38 | 1 | 23 | $1,079 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 38 | $1,079 |
Drugs they prescribed that Part D paid
$105,743
Pharmacies billed $105,743 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (18 of 1,981) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
1,751 generic and 215 brand-name prescriptions · $105,743 in drug cost · 130 antibiotic prescriptions to 109 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 27 | $31,626 | $1,171 |
| Paxlovid | 79 | $4,288 | $54 |
| Atorvastatin | 207 | $2,986 | $14 |
| Levothyroxine | 99 | $1,251 | $13 |
| Losartan | 68 | $871 | $13 |
See all 49 drugs
| Eliquis | 27 | $31,626 | $1,171 |
| Paxlovid | 79 | $4,288 | $54 |
| Atorvastatin | 207 | $2,986 | $14 |
| Levothyroxine | 99 | $1,251 | $13 |
| Losartan | 68 | $871 | $13 |
| Amlodipine Besylate | 132 | $753 | $6 |
| Metoprolol | 47 | $646 | $14 |
| Clopidogrel | 24 | $629 | $26 |
| Lisinopril | 69 | $613 | $9 |
| Tamsulosin | 21 | $604 | $29 |
| Ezetimibe | 12 | $580 | $48 |
| Levetiracetam | 13 | $545 | $42 |
| Diclofenac | 14 | $542 | $39 |
| Oxybutynin Chloride | 11 | $493 | $45 |
| Gabapentin | 25 | $443 | $18 |
| Carvedilol | 20 | $435 | $22 |
| Sertraline | 27 | $431 | $16 |
| Albuterol Sulfate Hfa | 21 | $426 | $20 |
| Fluticasone Propionate | 28 | $397 | $14 |
| Hydrocodone-Acetaminophen | 12 | $356 | $30 |
| Rosuvastatin | 43 | $341 | $8 |
| Levoxyl | 11 | $337 | $31 |
| Pantoprazole | 13 | $328 | $25 |
| Propranolol | 11 | $305 | $28 |
| Metformin | 47 | $274 | $6 |
| Furosemide | 36 | $236 | $7 |
| Trazodone | 24 | $225 | $9 |
| Chlorhexidine Gluconate | 17 | $210 | $12 |
| Simvastatin | 26 | $202 | $8 |
| Benazepril | 27 | $196 | $7 |
| Metformin Hcl Er | 24 | $188 | $8 |
| Allopurinol | 20 | $180 | $9 |
| Amoxicillin-Clavulanate Potass | 13 | $174 | $13 |
| Alendronate | 14 | $160 | $11 |
| Famotidine | 15 | $159 | $11 |
| Cephalexin | 31 | $141 | $5 |
| Mupirocin | 12 | $135 | $11 |
| Hydrochlorothiazide | 28 | $123 | $4 |
| Azithromycin | 35 | $121 | $3 |
| Duloxetine | 13 | $117 | $9 |
| Nitrofurantoin Mono-Macro | 14 | $111 | $8 |
| Clonazepam | 19 | $111 | $6 |
| Citalopram Hbr | 11 | $98 | $9 |
| Donepezil | 15 | $96 | $6 |
| Sulfamethoxazole-Trimethoprim | 15 | $75 | $5 |
| Atenolol | 24 | $60 | $2 |
| Celecoxib | 11 | $50 | $5 |
| Ciprofloxacin | 14 | $50 | $4 |
| Cyclobenzaprine | 11 | $14 | $1 |
Year by year
| 2024 | 1,981 | 414 | 1% (18) | 11% | $105,743 |
| 2023 | 1,987 | 520 | 2% (31) | 7% | $112,750 |
| 2022 | 1,243 | 197 | 2% (30) | 9% | $104,940 |
| 2021 | 851 | 126 | 3% (26) | 8% | $56,432 |
| 2020 | 195 | 32 | 0% (0) | None | $17,659 |
| 2019 | 327 | 34 | 0% (0) | None | $21,357 |
| 2018 | 173 | 40 | 0% (0) | 16% | $6,080 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 49 drugs
| Eliquis | 30 | $33,918 | $1,131 |
| Breo Ellipta | 12 | $5,228 | $436 |
| Atorvastatin | 150 | $2,603 | $17 |
| Amlodipine Besylate | 129 | $1,392 | $11 |
| Paxlovid (Eua) | 135 | $1,388 | $10 |
| Levothyroxine | 90 | $1,149 | $13 |
| Nifedipine Er | 15 | $957 | $64 |
| Metoprolol | 37 | $855 | $23 |
| Tamsulosin | 23 | $844 | $37 |
| Diclofenac | 15 | $834 | $56 |
| Oxybutynin Chloride | 13 | $696 | $54 |
| Losartan | 61 | $659 | $11 |
| Fluticasone Propionate | 27 | $627 | $23 |
| Benazepril | 24 | $605 | $25 |
| Trazodone | 24 | $577 | $24 |
| Lisinopril | 43 | $570 | $13 |
| Albuterol Sulfate Hfa | 13 | $550 | $42 |
| Clopidogrel | 20 | $477 | $24 |
| Metformin | 40 | $440 | $11 |
| Simvastatin | 28 | $432 | $15 |
| Gabapentin | 30 | $429 | $14 |
| Omeprazole | 31 | $422 | $14 |
| Furosemide | 42 | $415 | $10 |
| Pantoprazole | 23 | $377 | $16 |
| Propranolol | 11 | $371 | $34 |
| Rosuvastatin | 33 | $363 | $11 |
| Hydrocodone-Acetaminophen | 14 | $352 | $25 |
| Azithromycin | 63 | $328 | $5 |
| Nitrofurantoin Mono-Macro | 23 | $309 | $13 |
| Carvedilol | 17 | $300 | $18 |
| Clonazepam | 21 | $262 | $12 |
| Amoxicillin-Clavulanate Potass | 31 | $254 | $8 |
| Metoprolol | 37 | $233 | $6 |
| Sertraline | 18 | $199 | $11 |
| Atenolol | 19 | $181 | $10 |
| Losartan-Hydrochlorothiazide | 11 | $172 | $16 |
| Metformin Hcl Er | 19 | $169 | $9 |
| Hydrochlorothiazide | 27 | $164 | $6 |
| Lorazepam | 12 | $146 | $12 |
| Escitalopram | 27 | $144 | $5 |
| Cephalexin | 19 | $132 | $7 |
| Zolpidem | 17 | $121 | $7 |
| Citalopram Hbr | 12 | $101 | $8 |
| Meloxicam | 20 | $99 | $5 |
| Allopurinol | 15 | $82 | $5 |
| Cyclobenzaprine | 15 | $77 | $5 |
| Ciprofloxacin | 13 | $77 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $62 | $6 |
| Prednisone | 15 | $27 | $2 |
2022: 32 drugs
| Eliquis | 26 | $30,691 | $1,180 |
| Nifedipine Er | 22 | $1,474 | $67 |
| Atorvastatin | 94 | $1,359 | $14 |
| Tamsulosin | 28 | $1,123 | $40 |
| Amlodipine Besylate | 91 | $906 | $10 |
| Rosuvastatin | 23 | $836 | $36 |
| Levothyroxine | 49 | $729 | $15 |
| Oxybutynin Chloride | 13 | $674 | $52 |
| Losartan | 57 | $662 | $12 |
| Metoprolol | 32 | $635 | $20 |
| Hydrocodone-Acetaminophen | 21 | $617 | $29 |
| Clopidogrel | 22 | $479 | $22 |
| Lisinopril | 46 | $474 | $10 |
| Gabapentin | 28 | $451 | $16 |
| Metformin Hcl Er | 20 | $426 | $21 |
| Simvastatin | 23 | $353 | $15 |
| Benazepril | 16 | $332 | $21 |
| Nitrofurantoin Mono-Macro | 14 | $327 | $23 |
| Trazodone | 19 | $262 | $14 |
| Fluticasone Propionate | 12 | $256 | $21 |
| Carvedilol | 12 | $221 | $18 |
| Furosemide | 22 | $196 | $9 |
| Paxlovid (Eua) | 21 | $189 | $9 |
| Hydrochlorothiazide | 30 | $184 | $6 |
| Metoprolol | 16 | $152 | $9 |
| Omeprazole | 13 | $145 | $11 |
| Clonazepam | 23 | $145 | $6 |
| Atenolol | 16 | $132 | $8 |
| Allopurinol | 13 | $123 | $9 |
| Metformin | 23 | $92 | $4 |
| Zolpidem | 11 | $44 | $4 |
| Sertraline | 12 | $40 | $3 |
2021: 24 drugs
| Eliquis | 13 | $9,857 | $758 |
| Nifedipine Er | 20 | $1,285 | $64 |
| Atorvastatin | 54 | $701 | $13 |
| Losartan | 52 | $678 | $13 |
| Metoprolol | 27 | $665 | $25 |
| Tamsulosin | 24 | $520 | $22 |
| Fluticasone Propionate | 13 | $481 | $37 |
| Amlodipine Besylate | 63 | $472 | $7 |
| Triamcinolone Acetonide | 14 | $462 | $33 |
| Levothyroxine | 26 | $429 | $17 |
| Hydrocodone-Acetaminophen | 25 | $382 | $15 |
| Gabapentin | 25 | $323 | $13 |
| Trazodone | 29 | $320 | $11 |
| Pantoprazole | 18 | $260 | $14 |
| Clopidogrel | 12 | $242 | $20 |
| Lisinopril | 23 | $189 | $8 |
| Benazepril | 15 | $104 | $7 |
| Furosemide | 19 | $103 | $5 |
| Sertraline | 15 | $96 | $6 |
| Omeprazole | 15 | $93 | $6 |
| Hydrochlorothiazide | 19 | $88 | $5 |
| Clonazepam | 18 | $83 | $5 |
| Atenolol | 11 | $71 | $6 |
| Metformin | 12 | $49 | $4 |
2020: 5 drugs
| Albuterol Sulfate Hfa | 11 | $535 | $49 |
| Atorvastatin | 13 | $124 | $10 |
| Metoprolol | 16 | $120 | $8 |
| Losartan | 18 | $108 | $6 |
| Metformin | 11 | $22 | $2 |
2019: 6 drugs
| Atorvastatin | 44 | $390 | $9 |
| Omeprazole | 13 | $123 | $9 |
| Amlodipine Besylate | 26 | $91 | $3 |
| Metformin | 16 | $66 | $4 |
| Lisinopril | 16 | $54 | $3 |
| Losartan | 18 | $49 | $3 |
2018: 2 drugs
| Atorvastatin | 12 | $116 | $10 |
| Amlodipine Besylate | 12 | $39 | $3 |
Money from drug and device companies
$517 in 2025
| 2025 | 4 | 4 | None | $517 |
| 2024 | 3 | 3 | None | $404 |
| 2023 | 4 | 4 | None | $452 |
| 2021 | 1 | 1 | None | $100 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sanofi-Aventis U.S. | Tzield | $150 | 1 payment
|
| ViiV Healthcare | Apretude | $125 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $125 | 1 payment
|
| Lilly USA | Kisunla | $117 | 1 payment
|
See all 4 published payments
| Lilly USA | Meals · 2025-09-17 | Kisunla | $117 |
| ViiV Healthcare | Meals · 2025-08-20 | Apretude | $125 |
| Otsuka America Pharmaceutical | Meals · 2025-06-18 | Rexulti | $125 |
| Sanofi-Aventis U.S. | Meals · 2025-03-19 | Tzield | $150 |
See earlier years (2024, 2023, 2021)
2024: $404
| Lilly USA | Mounjaro | $154 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $125 | 1 payment
|
| Mayne Pharma Commercial | Annovera | $125 | 1 payment
|
2023: $452
| Otsuka America Pharmaceutical | Rexulti | $125 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $123 | 1 payment
|
| GlaxoSmithKline | None | $122 | 1 payment
|
| Lilly USA | Mounjaro | $83 | 1 payment
|
2021: $100
| Biohaven Pharmaceuticals | Nurtec Odt | $100 | 1 payment
|
Professional record
- NPI
- 1033640800
- Licence
- CA A169496California A169496: Current · expires 2028-07-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-03-23
- NPI last updated
- 2020-09-15
- NPI record certified
- 2020-09-15
This is when the NPI record was last certified, not a medical board exam.